Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancers

Optimal Pathologic Staging: Defining Stage II Disease

Carolyn C. Compton
Carolyn C. Compton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-07-1398 Published November 2007
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

Volume 13, Issue 22, pp. 6862s-6870s

DOI 
https://doi.org/10.1158/1078-0432.CCR-07-1398
PubMed 
18006791

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Accepted September 17, 2007
  • Received June 6, 2007
  • Revision received September 5, 2007
  • Published first November 15, 2007.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Carolyn C. Compton
  1. Author's Affiliation: Office of Biorepositories and Biospecimen Research, National Cancer Institute, Bethesda, Maryland
  1. Requests for reprints:
    Carolyn C. Compton, Office of Biorepositories and Biospecimen Research, National Cancer Institute, 31 Center Drive, Bethesda, MD 20892. Phone: 301-496-2741; E-mail: comptcar{at}mail.nih.gov.
View Full Text

PreviousNext
Back to top
Clinical Cancer Research: 13 (22)
November 2007
Volume 13, Issue 22
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Optimal Pathologic Staging: Defining Stage II Disease
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
Citation Tools
Optimal Pathologic Staging: Defining Stage II Disease
Carolyn C. Compton
Clin Cancer Res November 15 2007 (13) (22) 6862s-6870s; DOI: 10.1158/1078-0432.CCR-07-1398

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Optimal Pathologic Staging: Defining Stage II Disease
Carolyn C. Compton
Clin Cancer Res November 15 2007 (13) (22) 6862s-6870s; DOI: 10.1158/1078-0432.CCR-07-1398
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Pathologic Issues in Stage Assessment
    • Additional Pathologic Issues: Features That Modify Risk in Stage II Colorectal Cancer
    • Conclusions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Newer Pathologic Assessment Techniques for Colorectal Carcinoma
  • Optimal Methods for Staging Rectal Cancer
  • Management of Early Rectal T1 and T2 Cancers
Show more New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancers
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement